FMR LLC 13D/13G Filings for Ambrx Biopharma Inc. (AMAM)

FMR LLC 13D and 13G filings for Ambrx Biopharma Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2023-02-09
08:23 am
Sale		2023-02-0913GAmbrx Biopharma Inc.
AMAM		FMR LLC18,872,448
6.981%		-7,936,866decrease
(-29.60%)		Filing
2022-03-10
09:48 am
Sale		2022-03-0913GAmbrx Biopharma Inc.
AMAM		FMR LLC26,809,314
10.683%		-175,861decrease
(-0.65%)		Filing
2022-02-09
09:09 am
Purchase		2022-02-0813GAmbrx Biopharma Inc.
AMAM		FMR LLC26,985,175
9.996%		26,985,175increase
(New Position)		Filing